今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02225 今海医疗科技

已收盘 08-12 16:08:08

4.980

+0.110

+2.26%

最高4.990	最低4.670	成交量323.00万
今开4.800	昨收4.870	日振幅6.57%
总市值263.89亿	流通市值263.89亿	总股本52.99亿
成交额1,569万	换手率0.06%	流通股本52.99亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02225","market":"HK","secType":"STK","nameCN":"今海医疗科技","latestPrice":4.98,"timestamp":1786522088005,"preClose":4.87,"halted":0,"volume":3230000,"delay":0,"changeRate":0.0225872689938399,"floatShares":5299000000,"shares":5299000000,"eps":-0.003274,"marketStatus":"已收盘","change":0.11,"latestTime":"08-12 16:08:08","open":4.8,"high":4.99,"low":4.67,"amount":15694500,"amplitude":0.065708,"askPrice":4.99,"askSize":40000,"bidPrice":4.98,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.019812,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786584600000},"marketStatusCode":5,"adr":0,"listingDate":1508169600000,"exchange":"SEHK","adjPreClose":4.87,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"volumeRatio":0.615032,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02225","defaultTab":"news","newsList":[{"id":"1151056070","title":"一周港股牛熊榜 | 真健康医疗-B受手术机器人收费框架催化涨逾32%，中国星集团获资金追捧涨逾30%；东阳光药利好兑现跌近15%，京能清洁能源盈警拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=1151056070","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151056070?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:18","pubTimestamp":1786094280,"startTime":"0","endTime":"0","summary":"本周涨幅居前个股中，真健康医疗-B受手术机器人收费框架落地及行业商业化预期推动，累计上涨32.61%；中国星集团在影视娱乐股活跃及大手成交带动下上涨30.69%；海清智元获东吴证券国际首次覆盖并给予“买入”评级，累计上涨30.68%。按2025年经皮穿刺手术机器人收入计，公司在中国位居首位，市场份额为28.0%。","market":"hk","thumbnail":"https://static.tigerbbs.com/144fcf63ccaceb7d59c371695c704fb3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/144fcf63ccaceb7d59c371695c704fb3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00326","01392","02225","02697","02706"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1167350117","title":"今海医疗科技(02225)拟于2026年8月27日召开董事会审议中期业绩及股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1167350117","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167350117?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:36","pubTimestamp":1785832564,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司(02225)8月4日发布公告称，公司董事会已定于2026年8月27日(星期四)召开会议。届时，董事会将审议并批准包括截至2026年6月30日止六个月的中期业绩及可能派发的中期股息等事项。\n公告显示，目前公司董事会共由八名董事组成，其中包括四名执行董事、 一名非执行董事及三名独立非执行董事。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656320483","title":"今海医疗科技(02225)：马成栋获委任为首席营销官","url":"https://stock-news.laohu8.com/highlight/detail?id=2656320483","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656320483?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:13","pubTimestamp":1785751992,"startTime":"0","endTime":"0","summary":"智通财经APP讯，今海医疗科技(02225)发布公告，马成栋先生获委任为集团首席营销官，自2026年8月3日起生效，初步任期为一年，主要负责集团产品的营销策略、市场准入、学术推广及销售与渠道营运，并监督集团医疗器械及设备产品的商业化工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1150","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125920054","title":"今海医疗科技更新2026年7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125920054","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125920054?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:18","pubTimestamp":1785748737,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年8月3日披露2026年7月的股份变动月报表。报告显示，截至2026年7月31日，公司法定股本总额保持在8,000,000,000股普通股，面值每股HKD0.0025，合计HKD20,000,000，与上月同步数据相同。根据公告，今海医疗科技自2023年12月29日起实施的股份期权计划共有445,960,000份期权，截至7月底数量未发生变化，当月亦无新股因行使期权而发行或从库存转让。公司表示，所有申报及变动事项均已遵守香港联交所《上市规则》和相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656326429","title":"港股异动 | 今海医疗科技(02225)涨超6% 微创手术器械市场发展迅速 公司切入内窥镜国产替代黄金赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2656326429","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656326429?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:16","pubTimestamp":1785741407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今海医疗科技涨超6%，截至发稿，涨5.63%，报3.845港元，成交额1041.77万港元。消息面上，据MordorIntelligence报告指出，随着行业参与者适应不断变化的临床标准及患者需求，微创手术器械市场发展迅速。中国微创手术器械市场为全球增长最快的手术器械市场之一。报告还指出，中国微创手术器械行业2025年市场规模为17.1亿美元，预计2030年将增至26.8亿美元，复合年增长率为9.45%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475209.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JDST","GDXD","GOLY","02225","1OZmain","GCmain","GLDM","VXUS","GDX","IAUM","DULL","DGP","GBUG","GLTR","SGOL","159831","PICK","XHE","DZZ","AAAU","BTGD","USG","QOmain","GDXJ","GDXU","BEGS","DBC","XME","PALL","GOAU","GDXY","OUNZ","BAR","RING","SGDM","SHNY","FGDL","GLL","KCAI","UGL","KSTR","IAUI","PHYS","FAAR","MGCmain","CEF","IAU","JNUG","UYM","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653822207","title":"港股异动 | 今海医疗科技(02225)涨超14% 获韩国投资者逆势加仓 公司深耕国内微创手术领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2653822207","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653822207?lang=zh_cn&edition=full","pubTime":"2026-07-21 15:52","pubTimestamp":1784620338,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，今海医疗科技涨超14%，截至发稿，涨14.64%，报4.15港元，成交额1.47亿港元。港股市场方面，包括今海医疗科技在内的标的获净买入金额也在百万美元以上。据悉，今海医疗专注于高端医疗内窥镜等微创医疗器械整体解决方案，凭借近年来在内窥镜技术研发领域持续深耕，今海取得了多项重要突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02225","BK1150","VXUS","BK4585","KCAI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155480992","title":"今海医疗科技6月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1155480992","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155480992?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:06","pubTimestamp":1782979589,"startTime":"0","endTime":"0","summary":"今海医疗科技于2026年7月2日发布截至2026年6月30日的证券变动月报表。公告显示，公司截至本月底的法定/注册股本及已发行股份数均保持不变，股本规模继续维持稳定。此外，根据公司于2023年12月29日采纳的股份期权计划，期末股份期权数量为445,960,000份，与上月相比无变动，报告期内并未产生新的股份发行或需从库存转让股份的情形。公司在公告中确认已遵守香港联交所《上市规则》及相关法律规定。该公告由公司秘书黄文耀签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641085091","title":"降价、分化、出海与咖啡，新茶饮六小龙开始算 “生态账”","url":"https://stock-news.laohu8.com/highlight/detail?id=2641085091","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641085091?lang=zh_cn&edition=full","pubTime":"2026-06-08 11:28","pubTimestamp":1780889289,"startTime":"0","endTime":"0","summary":"蜜雪稳坐王座，体量碾压，增长态势强劲。但其利润表现亮眼，净利润8.21亿元，同比大增71.2%。门店总数从1798家缩减至1646家，首次出现门店负增长。增速分化的原因，与门店经营状态密切相关。霸王茶姬大中华区单店日均GMV从2023年Q4高峰期的1.91万元，连续8个季度下滑至2025年Q4的1.12万元。截至6月2日，蜜雪集团以1081.91亿港元的总市值稳居头把交椅。“六小龙”给出了不同的答案。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1780578798494969439","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4526","LU0348767384.USD","CHA","BK4539","BK4610","BK1110","BK1616","02198","LU0348766576.USD","BK1150","BK1233","02555","02150","BK1237","BK1587","BK4209","02226","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143551022","title":"今海医疗科技更新5月股份变动月报表，已发行股份增至52.99亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143551022","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143551022?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:06","pubTimestamp":1780301165,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年6月1日发布截至2026年5月31日的月报表。公告显示，公司法定/注册股本维持与上月相同，数额为2,000万港元，股份面值为每股0.0025港元，法定/注册股份总数保持在80亿股。在已发行股份方面，5月期内公司普通股数量由上月底的52.90亿股增加至52.99亿股，增发9,000,000股。库藏股数量持续为0，已发行股份套数相应增长至52.99亿股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638066685","title":"异动股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638066685","media":"财华网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638066685?lang=zh_cn&edition=full","pubTime":"2026-05-28 16:20","pubTimestamp":1779956406,"startTime":"0","endTime":"0","summary":"05月28日收盘，截至发稿，港股跌幅榜前十名分别为智中国际跌幅29.76%、金石资本集团跌幅25.38%、高奥士人才集团跌幅24.05%、华亿金控(新)跌幅21.88%、亦辰集团跌幅20.67%、GUANZE MEDICAL跌幅20.00%、华联国际跌幅19.13%、迪米生活控股跌幅18.92%、今海医疗科技跌幅18.04%、迪诺斯环保跌幅17.32%。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/28162057239515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01452","01160","BK1147","08365","BK1150","BK1148","BK1183","08042","01667","BK1239","06063","00969","08123","BK1156","BK1197","BK1212","02427","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174339980","title":"今海医疗科技拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1174339980","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174339980?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:32","pubTimestamp":1778581960,"startTime":"0","endTime":"0","summary":"今海医疗科技于开曼群岛注册成立，并在香港联合交易所有限公司主板上市。公司近期发布公告，董事会将于2026年6月15日召开的股东周年大会上，寻求批准一项股份购回授权，规模最高可达已发行股份总数的10%。公告亦提及，公司将于2026年6月10日至2026年6月15日期间暂停办理股份过户登记，以确定合资格投票的股东身份。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"今海医疗科技拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180238226","title":"今海医疗科技更新2026年4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1180238226","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180238226?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:10","pubTimestamp":1777882259,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年5月4日发布了截至2026年4月30日的股份变动月报表，披露公司报告期内股本未发生变动。公司法定注册股本金额为港币2,000万元，股份总数为8,000,000,000股，面值每股港币0.0025。关于期权与激励计划方面，截至本月底，公司在2023年12月29日所采纳的股份期权计划下，已授出的股份期权合计4.5496亿份，与上月末持平。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113490938","title":"异动解读 | 今海医疗科技盘中大跌5.45%，疑遭大手卖出打压","url":"https://stock-news.laohu8.com/highlight/detail?id=1113490938","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113490938?lang=zh_cn&edition=full","pubTime":"2026-04-29 13:50","pubTimestamp":1777441853,"startTime":"0","endTime":"0","summary":"今海医疗科技今日盘中大跌5.45%，引起了市场的关注。消息面上，该股在午盘时段出现多笔大手卖出交易。根据市场数据显示，在股价下跌前，从下午1点14分至1点20分期间，连续出现多笔大额卖单，涉及股数从77.5万股到130万股不等，成交价集中在4.38港元至4.39港元区间。分析人士指出，短时间内密集出现的大手卖出可能对股价形成压力，导致市场情绪转向谨慎，进而引发股价的显著下跌。这些大额交易可能反映了部分机构或大股东的资金动向。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149425024","title":"今海医疗科技2025年营收下滑至约4,627.60万新加坡元 资产规模与股本同步显著提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1149425024","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149425024?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:44","pubTimestamp":1777020278,"startTime":"0","endTime":"0","summary":"今海医疗科技在本年度持续聚焦微创手术解决方案及医疗产品与相关服务，报告期内录得收入约4,627.60万新加坡元，同比下降约7.9%。其中，微创手术和医疗相关业务收入由约2,592.70万新加坡元升至约2,996.40万新加坡元，显示部分新技术投入带动增量；劳务派遣及宿舍服务等板块则因业务调整呈现下滑。受成本及市场环境等因素影响，公司年内亏损约为1,739.50万新加坡元，毛利由约1,147.70万新加坡元降至约718.90万新加坡元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"今海医疗科技2025年营收下滑至约4,627.60万新加坡元 资产规模与股本同步显著提升","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151217443","title":"一周港股牛熊榜 | 滴普科技飙近70%领跑，五一视界、剑桥科技强势爆发；健康160重挫35%领跌，力勤资源、果下科技同步走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1151217443","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151217443?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:24","pubTimestamp":1776417895,"startTime":"0","endTime":"0","summary":"叠加整个港股科技板块当日受美伊缓和、AI生态爆发等因素提振大幅走强的大环境，共同推动了滴普科技本周的强势表现。$五一视界$  本周累升逾60%，物理AI模型重大突破叠加创始人增持引爆行情港股\"物理AI第一股\"五一视界股价连续拉升，本周累计升幅逾60%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02245","06613","03881","06651","06166","02225","02655","02656","00100","01384"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1142728419","title":"异动解读 | 今海医疗科技盘中大跌5.44%，因出现大手卖出76.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1142728419","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142728419?lang=zh_cn&edition=full","pubTime":"2026-04-13 09:42","pubTimestamp":1776044552,"startTime":"0","endTime":"0","summary":"今海医疗科技(02225)今日盘中股价大跌5.44%，引起了市场的关注。消息面上，该股在盘中出现大手卖出，成交量为76.5万股，成交价为2.32港元，涉资177.48万港元。这笔大额卖出可能引发了市场抛售情绪，导致股价进一步下挫。目前，今海医疗科技的股价波动较大，投资者需谨慎关注后续市场动态。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143768032","title":"今海医疗科技更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143768032","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143768032?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:07","pubTimestamp":1775030868,"startTime":"0","endTime":"0","summary":"今海医疗科技股份有限公司于2026年4月1日披露2026年3月股份变动月报表，报告期为2026年3月。整体来看，截至报告期末，公司股本结构维持稳定，符合香港联交所的公众持股量要求。该公告由公司秘书黄文耀签署，公司同时确认遵守香港联交所《上市规则》及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114181270","title":"异动解读 | 今海医疗科技盘中大涨7.73%，因出现大手买入","url":"https://stock-news.laohu8.com/highlight/detail?id=1114181270","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114181270?lang=zh_cn&edition=full","pubTime":"2026-03-31 13:32","pubTimestamp":1774935168,"startTime":"0","endTime":"0","summary":"今海医疗科技今日盘中股价大幅上涨7.73%，引起了市场的广泛关注。消息面上，根据相关交易数据，该股票在盘中时段出现显著的大手买入活动，其中一笔涉及260万股，成交价为2.19港元，涉资约569.4万港元；另一笔涉及390万股，成交价为2.2港元，涉资约858万港元，这些集中且大额的资金流入被认为是推动股价快速攀升的主要动力。此类大手交易通常表明有机构投资者或大资金对该公司表示出兴趣，并在短期内积极建仓，从而带动了市场情绪和股价表现。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622879118","title":"今海医疗科技(02225)发布年度业绩，股东应占亏损1708万新加坡元 同比减少4.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622879118","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622879118?lang=zh_cn&edition=full","pubTime":"2026-03-28 00:37","pubTimestamp":1774629470,"startTime":"0","endTime":"0","summary":"智通财经APP讯，今海医疗科技(02225)发布截至2025年12月31日止年度业绩，该集团取得收益4627.6万新加坡元，同比减少7.89%;公司拥有人应占亏损1708万新加坡元，同比减少4.9%;每股亏损0.33新加坡分。公告称，本集团于2025财年取得亏损1740万新加坡元(2024财年：1830万新加坡元)，主要由于行政开支减少750万新加坡元，被毛利减少所抵销。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1150","02225"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175023810","title":"异动解读 | 今海医疗科技盘中大涨6.05%，因出现大手买入","url":"https://stock-news.laohu8.com/highlight/detail?id=1175023810","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175023810?lang=zh_cn&edition=full","pubTime":"2026-03-27 13:40","pubTimestamp":1774590041,"startTime":"0","endTime":"0","summary":"今海医疗科技(02225)今日盘中股价大幅上涨6.05%，引起市场关注。消息面上，该股在盘中出现一笔大手买入交易，成交量为340万股，成交价为2.29港元，涉及资金约778.6万港元。这笔大额资金的流入，直接推动了股价的显著上扬。市场分析认为，此类大手买入通常反映了机构投资者或大资金对公司的积极看法，可能基于对公司基本面的信心或特定利好消息的预期，从而带动了股价的短期强势表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02225"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://kttgroup.com.sg/","stockEarnings":[{"period":"1week","weight":0.1043},{"period":"1month","weight":0.4848},{"period":"3month","weight":0.1247},{"period":"6month","weight":1.5632},{"period":"1year","weight":2.4786},{"period":"ytd","weight":2.896}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":0.0611},{"period":"3month","weight":-0.0279},{"period":"6month","weight":-0.051},{"period":"1year","weight":0.03},{"period":"ytd","weight":0.0009}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"今海医疗科技股份有限公司是一家总部位于新加坡的投资控股公司。该公司及其运营子公司为建筑行业提供人力外包及配套服务、宿舍服务、信息技术（IT）服务、建筑配套服务，以及微创手术解决方案、医疗产品及相关服务。该公司的业务范围覆盖新加坡和中华人民共和国。今海医疗是一家提供人力资源和空间管理的综合解决方案提供商。香港今海企业发展有限公司是该公司的子公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.079873},{"month":2,"riseRate":0.444444,"avgChangeRate":0.213927},{"month":3,"riseRate":0.777778,"avgChangeRate":0.120644},{"month":4,"riseRate":0.333333,"avgChangeRate":0.069575},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.067852},{"month":6,"riseRate":0.666667,"avgChangeRate":0.015787},{"month":7,"riseRate":0.666667,"avgChangeRate":0.089839},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009308},{"month":9,"riseRate":0.625,"avgChangeRate":0.128529},{"month":10,"riseRate":0.375,"avgChangeRate":-0.001574},{"month":11,"riseRate":0.555556,"avgChangeRate":0.116404},{"month":12,"riseRate":0.666667,"avgChangeRate":0.003541}],"exchange":"SEHK","name":"今海医疗科技","nameEN":"JINHAI MED TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供今海医疗科技(02225)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"今海医疗科技,02225,今海医疗科技股票,今海医疗科技股票老虎,今海医疗科技股票老虎国际,今海医疗科技行情,今海医疗科技股票行情,今海医疗科技股价,今海医疗科技股市,今海医疗科技股票价格,今海医疗科技股票交易,今海医疗科技股票购买,今海医疗科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"今海医疗科技(02225)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供今海医疗科技(02225)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}